All Stories

  1. Claudin-3, Lipopolysaccharide Binding Protein, and Jaundice Clearance in Infants with Biliary Atresia

    Article • The Journal of Pediatrics, November 2025, Elsevier

    Dr Antonio Riva

  2. Evidence for alcohol-mediated hemolysis and erythrophagocytosis

    Article • Redox Biology, September 2025, Elsevier

    Dr Antonio Riva

  3. Pediatric Liver and Kidney Transplant Recipients Demonstrate Greater Serological Response to SARS-CoV-2 Vaccination Than Adults

    Article • Transplantation Direct, April 2025, Wolters Kluwer Health

    Dr Antonio Riva, Dr Vishal C Patel

  4. Soluble Herpes Virus Entry Mediator and Type II/III Interferons Are Upregulated in Primary Biliary Cholangitis

    Article • International Journal of Molecular Sciences, January 2025, MDPI AG

    Dr Antonio Riva

  5. Osteopontin Promotes Cholangiocyte Secretion of Chemokines to Support Macrophage Recruitment and Fibrosis in MASH

    Article • Liver International, October 2024, Wiley

    Dr Antonio Riva

  6. High-Resolution Magic Angle Spinning Nuclear Magnetic Resonance Spectroscopy of Paired Clinical Liver Tissue Samples from Hepatocellular Cancer and Surrounding Region

    Article • International Journal of Molecular Sciences, August 2024, MDPI AG

    Dr Antonio Riva

  7. Effects of SGLT2 Ablation or Inhibition on Corticosterone Secretion in High-Fat-Fed Mice: Exploring a Nexus with Cytokine Levels

    Article • April 2024, Cold Spring Harbor Laboratory Press

    Dr Antonio Riva

  8. Reducing the harms of alcohol: nutritional interventions and functional alcohol alternatives

    Article • January 2024, Elsevier

    Dr Antonio Riva

  9. Human Precision-Cut Liver Slices: A Potential Platform to Study Alcohol-Related Liver Disease

    Article • International Journal of Molecular Sciences, December 2023, MDPI AG

    Dr Antonio Riva

  10. Serological response and breakthrough infection after COVID-19 vaccination in patients with cirrhosis and post-liver transplant

    Article • Hepatology Communications, October 2023, Wolters Kluwer Health

    Dr Vishal C Patel, Xavier Verhelst, Dr Antonio Riva

  11. Editorial: Soluble immune checkpoints: Novel physiological immunomodulators

    Article • Frontiers in Immunology, March 2023, Frontiers

    Dr Antonio Riva

  12. Human Immunocompetent Model of Neuroendocrine Liver Metastases Recapitulates Patient-Specific Tumour Microenvironment

    Article • Frontiers in Endocrinology, July 2022, Frontiers

    Dr Antonio Riva

  13. A review of alcohol–pathogen interactions: New insights into combined disease pathomechanisms

    Article • Alcoholism Clinical and Experimental Research, February 2022, Wiley

    Moses New-Aaron , Dr Antonio Riva

  14. Inflammation in alcohol-associated liver disease progression

    Article • Zeitschrift für Gastroenterologie, January 2022, Thieme Publishing Group

    Dr Antonio Riva

  15. Soluble TIM3 and Its Ligands Galectin-9 and CEACAM1 Are in Disequilibrium During Alcohol-Related Liver Disease and Promote Impairment of Anti-bacterial Immunity

    Article • Frontiers in Physiology, March 2021, Frontiers

    Dr Antonio Riva

  16. Intestinal Barrier Function in Health and Disease—Any Role of SARS-CoV-2?

    Article • Microorganisms, November 2020, MDPI AG

    Dr Antonio Riva

  17. Faecal cytokine profiling as a marker of intestinal inflammation in acutely decompensated cirrhosis

    Article • JHEP Reports, July 2020, Elsevier

    Dr Vishal C Patel, Dr Antonio Riva

  18. Perturbations in Mitochondrial Dynamics Are Closely Involved in the Progression of Alcoholic Liver Disease

    Article • Alcoholism Clinical and Experimental Research, February 2020, Wiley

    Dr Antonio Riva

  19. Scientific Business Abstracts of the 113th Annual Meeting of the Association of Physicians of Great Britain and Ireland

    Article • QJM, September 2019, Oxford University Press (OUP)

    Dr Richard Mark Monaghan, Dr Antonio Riva

  20. Regulation of Monocyte-Macrophage Responses in Cirrhosis—Role of Innate Immune Programming and Checkpoint Receptors

    Article • Frontiers in Immunology, February 2019, Frontiers

    Dr Antonio Riva

  21. Dynamin-1-like protein inhibition drives megamitochondria formation as an adaptive response in alcohol-induced hepatotoxicity

    Article • American Journal Of Pathology, December 2018, Elsevier

    Dr Antonio Riva

  22. Differential Expression of Immune Inhibitory Checkpoint Signatures on Antiviral and Inflammatory T Cell Populations in Chronic Hepatitis B

    Article • Journal of Interferon & Cytokine Research, July 2018, Mary Ann Liebert Inc

    Dr Antonio Riva

  23. Immune checkpoint receptors: homeostatic regulators of immunity

    Article • Hepatology International, May 2018, Springer Science + Business Media

    Dr Antonio Riva

  24. Can we reliably predict response to corticosteroid treatment in severe alcoholic hepatitis?

    Article • Hepatology Communications, April 2018, Wiley

    Dr Antonio Riva

  25. Mucosa-associated invariant T cells link intestinal immunity with antibacterial immune defects in alcoholic liver disease

    Article • Gut, November 2017, BMJ

    Dr Antonio Riva, Dr Vishal C Patel

  26. Fecal microbiota transplant from a rational stool donor improves hepatic encephalopathy: A randomized clinical trial

    Article • Hepatology, October 2017, Wiley

    Dr Antonio Riva

  27. Peg-Interferon Lambda Treatment Induces Robust Innate and Adaptive Immunity in Chronic Hepatitis B Patients

    Article • Frontiers in Immunology, May 2017, Frontiers

    Dr Antonio Riva

  28. Analysis of peripheral blood dendritic cells as a non-invasive tool in the follow-up of patients with chronic hepatitis C

    Article • World Journal of Gastroenterology, January 2016, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Antonio Riva

  29. Neutrophil Toll-Like Receptor 9 Expression and the Systemic Inflammatory Response in Acetaminophen-Induced Acute Liver Failure

    Article • Critical Care Medicine, January 2016, Wolters Kluwer Health

    Dr Antonio Riva, Dr Vishal C Patel

  30. Urinary nuclear magnetic resonance spectroscopy of a Bangladeshi cohort with hepatitis-B hepatocellular carcinoma: A biomarker corroboration study

    Article • World Journal of Gastroenterology, January 2016, Baishideng Publishing Group Co., Limited (formerly WJG Press)

    Dr Antonio Riva

  31. Blockade of PD1 and TIM3 Restores Innate and Adaptive Immunity in Patients With Acute Alcoholic Hepatitis

    Article • Gastroenterology, March 2015, Elsevier

    Dr Antonio Riva

  32. Alisporivir Inhibition of Hepatocyte Cyclophilins Reduces HBV Replication and Hepatitis B Surface Antigen Production

    Article • Gastroenterology, February 2015, Elsevier

    Dr Antonio Riva

  33. Truncated CXCL10 is associated with failure to achieve spontaneous clearance of acute hepatitis C infection

    Article • Hepatology, August 2014, Wolters Kluwer Health

    Dr Antonio Riva

  34. Osteopontin neutralisation abrogates the liver progenitor cell response and fibrogenesis in mice

    Article • Gut, June 2014, BMJ

    Dr Antonio Riva

  35. Identification of Serum Cytokine Profiles Associated with HBeAg Seroconversion Following Antiviral Treatment Interruption

    Article • Viral Immunology, June 2014, Mary Ann Liebert Inc

    Dr Antonio Riva

  36. Association of Water Softness and Heavy Alcohol Consumption with Higher Hospital Admission Rates for Alcoholic Liver Disease

    Article • Alcohol and Alcoholism, September 2012, Oxford University Press (OUP)

    Dr Antonio Riva

  37. Cytokine profiles in high risk injection drug users suggests innate as opposed to adaptive immunity in apparent resistance to hepatitis C virus infection

    Article • Journal of Viral Hepatitis, January 2012, Wiley

    Dr Antonio Riva

  38. Kinetics of hepatitis B surface antigen decline during 3 years of telbivudine treatment in hepatitis B e antigen-positive patients

    Article • Hepatology, October 2010, Wiley

    Dr Antonio Riva

  39. CD8+ T Cell Control of Hepatitis B Virus Replication: Direct Comparison between Cytolytic and Noncytolytic Functions

    Article • The Journal of Immunology, November 2009, The American Association of Immunologists

    Dr Antonio Riva

  40. Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion

    Article • Hepatology, September 2008, Wiley

    Dr Antonio Riva

  41. Decrease and dysfunction of dendritic cells correlate with impaired hepatitis C virus-specific CD4+T-cell proliferation in patients with hepatitis C virus infection

    Article • Immunology, June 2007, Wiley

    Dr Antonio Riva

  42. Quantitative and functional defects of dendritic cells in classic Kaposi's sarcoma

    Article • Clinical Immunology, June 2006, Elsevier

    Dr Antonio Riva

  43. Hepatitis C virus-specific reactivity of CD4+-lymphocytes in children born from HCV-infected women

    Article • Journal of Hepatology, September 2005, Elsevier

    Dr Antonio Riva

  44. Peripheral blood dendritic cells increase in kidney-transplant patients without rejection

    Article • Clinical Immunology, February 2004, Elsevier

    Dr Antonio Riva

  45. Altered maturation of peripheral blood dendritic cells in patients with breast cancer

    Article • British Journal of Cancer, October 2003, Nature

    Dr Antonio Riva

  46. Functional repertoire of dendritic cells generated in granulocyte macrophage-colony stimulating factor and interferon- 

    Article • Journal of Leukocyte Biology, October 2003, Society for Leukocyte Biology

    Dr Antonio Riva